Search Results - "Heng Mei"

Effect of interferon induced transmembrane protein 1 (IFITM1) upregulation to cytokine release syndrome in CAR-T-treated B-cell acute lymphoblastic leukemia

Mengyi Du, Yinqiang Zhang, Chenggong Li, Fen Zhou, Wenjing Luo, Lu Tang, Jianghua Wu, Huiwen Jiang, Qiuzhe Wei, Cong Lu, Haiming Kou, Yu Hu, Heng Mei, Xuehong Zhang

electronic resource

View item; View item; View item

Inaticabtagene autoleucel in adult relapsed or refractory B-cell acute lymphoblastic leukemia

Ying Wang, Lulu Lv, Yongping Song, Xudong Wei, Hongsheng Zhou, Qifa Liu, Kailin Xu, Dongmei Yan, Cheng Zhang, Shuangyou Liu, Jie Jin, Heng Mei, Ting Niu, Aibin Liang, Runxia Gu, Jienan Ren, Yi Feng, Wei Jin, Yan Zhou, Yiping Deng, Jianxiang Wang

electronic resource

View item; View item

Recent advances of chimeric antigen receptor T‐cell therapy for acute myeloid leukemia

Yang Liu, Wanting Wang, Chaofan Wang, Jun Deng, Yu Hu, Heng Mei, Shanshan Luo

electronic resource

View item; View item

Safety and clinical efficacy of Relmacabtagene autoleucel (relma-cel) for systemic lupus erythematosus: a phase 1 open-label clinical trialResearch in context

Jinhui Shu, Wei Xie, Chunli Mei, Anqi Ren, Sha Ke, Meilin Ma, Zisong Zhou, Yu Hu, Heng Mei

electronic resource

View item; View item

Microwave-assisted green synthesis, characterization, and in vitro antibacterial activity of NiO nanoparticles obtained from lemon peel extract

Heng Mei Hsuan, Win Yip Foo, Cheah Eddy Seong Guan, Chan Yu Bin, Rahman Md. Khalilur, Sultana Sabiha, Tey Lai-Hock, Wong Ling Shing, Djearamane Sinouvassane, Akhtaruzzaman Md., Aminuzzaman Mohammod

electronic resource

View item

Zanubrutinib plus R-CHOP improves the treatment effect of newly diagnosed diffuse large B cell lymphoma with double expression of MYC and BCL-2

Min Zhang, Yingying Wu, Zhipeng Cheng, Lu Zhang, Lin Liu, Fang Liu, Guohui Cui, Linghui Xia, Yu Hu, Heng Mei, Tao Guo, Jun Fang

electronic resource

View item; View item

Recommendations for the timing, dosage, and usage of corticosteroids during cytokine release syndrome (CRS) caused by chimeric antigen receptor (CAR)-T cell therapy for hematologic malignancies

Sanfang Tu, Xiu Luo, Heng Mei, Yongxian Hu, Yang Liu, Ping Li, Dehui Zou, Ting Niu, Kailin Xu, Xi Zhang, Lugui Qiu, Lei Gao, Guangxun Gao, Li Zhang, Yimei Feng, Ying Wang, Mingfeng Zhao, Jianqing Mi, Ming Hou, Jianmin Yang, He Huang, Jianxiang Wang, Yu Hu, Weili Zhao, Depei Wu, Jun Ma, Yuhua Li, Wenbin Qian, Xiaojun Huang, Weidong Han, Aibin Liang, Yanjie Yin

electronic resource

View item; View item; View item

Off-the-shelf CAR-T cell therapies for relapsed or refractory B-cell malignancies: latest update from ASH 2023 annual meeting

Yun Kang, Chenggong Li, Heng Mei

electronic resource

View item

Targeting autophagy overcomes cancer‐intrinsic resistance to CAR‐T immunotherapy in B‐cell malignancies

Lu Tang, Huan Zhang, Fen Zhou, Qiuzhe Wei, Mengyi Du, Jianghua Wu, Chenggong Li, Wenjing Luo, Jie Zhou, Xindi Wang, Zhaozhao Chen, Yinqiang Zhang, Zhongpei Huang, Zhuolin Wu, Yuxi Wen, Huiwen Jiang, Danying Liao, Haiming Kou, Wei Xiong, Heng Mei, Yu Hu

electronic resource

View item

Insights gained from single-cell analysis of chimeric antigen receptor T-cell immunotherapy in cancer

Lu Tang, Zhong-Pei Huang, Heng Mei, Yu Hu

electronic resource

View item

The diagnostic value of dual-layer CT in the assessment of lymph nodes in lymphoma patients with PET/CT as a reference standard

Zhengwu Tan, Heng Mei, Chunxia Qin, Xiao Zhang, Ming Yang, Lan Zhang, Jing Wang

electronic resource

View item

Targeting CD22 for B-cell hematologic malignancies

Jia Xu, Wenjing Luo, Chenggong Li, Heng Mei

electronic resource

View item

Zuberitamab, an innovative anti-CD20 monoclonal antibody, for patients with primary immune thrombocytopenia in China: a randomized, double-blind, placebo-controlled, phase 2 studyResearch in context

Min Xu, Jinhui Shu, Shenxian Qian, Jingming Guo, Yuping Gong, Ruibin Huang, Shuye Wang, Zeping Zhou, Guolin Yuan, Meijuan Huang, Li-E Lin, Shifeng Lou, Yanping Song, Qingchi Liu, Hu Zhou, Heng Mei, Yu Hu

electronic resource

View item; View item

Treatment of multiple myeloma: What is the impact on T-cell function?

Chenggong Li, Xindi Wang, Jia Xu, Jiachen Liu, Heng Mei

electronic resource

View item

Real-world experience of commercial relmacabtagene autoleucel (relma-cel) for relapsed/refractory central nervous system lymphoma: a multicenter retrospective analysis of patients in China

Hui Li, Peng Liu, Yao Liu, Liang Huang, Yuhua Li, QingQing Cai, Huilai Zhang, Jian-Qing Mi, Zhi Wang, Ting Niu, Dehui Zou, Wenyan Yu, Heng Mei, Jianqiu Wu

electronic resource

View item; View item

Platelet parameters for distinguishing between inherited macrothrombocytopenia and acquired thrombocytopenia: a retrospective case–control study

Wenlan Chen, Yajie Ding, Li Cai, Mei Xue, Abdul Rehman Arif, Heng Mei, Yadan Wang

electronic resource

View item; View item

Immunotherapy in hematologic malignancies: achievements, challenges and future prospects

Lu Tang, Zhongpei Huang, Heng Mei, Yu Hu

electronic resource

View item

Allogenic and autologous anti-CD7 CAR-T cell therapies in relapsed or refractory T-cell malignancies

Yinqiang Zhang, Chenggong Li, Mengyi Du, Huiwen Jiang, Wenjing Luo, Lu Tang, Yun Kang, Jia Xu, Zhuolin Wu, Xindi Wang, Zhongpei Huang, Yanlei Zhang, Di Wu, Alex H. Chang, Yu Hu, Heng Mei

electronic resource

View item

GPIbα CAAR-T cells function like a Trojan horse to eliminate autoreactive B cells to treat immune thrombocytopenia

Jie Zhou, Yanyan Xu, Jinhui Shu, Haojie Jiang, Linlin Huang, Min Xu, Junling Liu, Yu Hu, Heng Mei

electronic resource

View item; View item; View item

Elevating the potential of CAR-T cell therapy in solid tumors: exploiting biomaterials-based delivery techniques

Yuxiang Tang, Xiaoyu Yang, Hang Hu, Huiwen Jiang, Wei Xiong, Heng Mei, Yu Hu

electronic resource

View item; View item